- Home
- HBIO vs NOM Comparison
HBIO vs NOM Comparison
Compare HBIO & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- NOM
- Stock Information
- Founded
- HBIO 1901
- NOM 1993
- Country
- HBIO United States
- NOM United States
- Employees
- HBIO N/A
- NOM N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- NOM Investment Managers
- Sector
- HBIO Industrials
- NOM Finance
- Exchange
- HBIO Nasdaq
- NOM Nasdaq
- Market Cap
- HBIO 24.6M
- NOM 25.8M
- IPO Year
- HBIO 2000
- NOM N/A
- Fundamental
- Price
- HBIO $0.44
- NOM $11.00
- Analyst Decision
- HBIO Buy
- NOM
- Analyst Count
- HBIO 3
- NOM 0
- Target Price
- HBIO $2.50
- NOM N/A
- AVG Volume (30 Days)
- HBIO 1.1M
- NOM 6.9K
- Earning Date
- HBIO 11-06-2025
- NOM 01-01-0001
- Dividend Yield
- HBIO N/A
- NOM 3.39%
- EPS Growth
- HBIO N/A
- NOM N/A
- EPS
- HBIO N/A
- NOM N/A
- Revenue
- HBIO $88,750,000.00
- NOM N/A
- Revenue This Year
- HBIO N/A
- NOM N/A
- Revenue Next Year
- HBIO $7.02
- NOM N/A
- P/E Ratio
- HBIO N/A
- NOM N/A
- Revenue Growth
- HBIO N/A
- NOM N/A
- 52 Week Low
- HBIO $0.28
- NOM $8.52
- 52 Week High
- HBIO $2.82
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- HBIO 43.42
- NOM 49.81
- Support Level
- HBIO $0.43
- NOM $10.90
- Resistance Level
- HBIO $0.47
- NOM $11.19
- Average True Range (ATR)
- HBIO 0.02
- NOM 0.16
- MACD
- HBIO -0.00
- NOM -0.02
- Stochastic Oscillator
- HBIO 14.39
- NOM 30.43
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.